These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 23121631)

  • 1. A response to: Self-reported and actual hepatitis C virus infection status.
    O'Keefe D; Aitken C; Higgs P; Dietze P
    Drug Alcohol Rev; 2013 Jan; 32(1):107. PubMed ID: 23121631
    [No Abstract]   [Full Text] [Related]  

  • 2. Self-reported and actual hepatitis C virus infection status.
    Wiwanitkit V
    Drug Alcohol Rev; 2013 Jan; 32(1):106. PubMed ID: 23121657
    [No Abstract]   [Full Text] [Related]  

  • 3. Concordance between self-reported and actual hepatitis C virus infection status in a cohort of people who inject drugs.
    O'Keefe D; Aitken C; Higgs P; Dietze P
    Drug Alcohol Rev; 2013 Mar; 32(2):208-10. PubMed ID: 22943595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hepatitis C and drug use: epidemiology, screening, natural history and treatment].
    Lucidarme D
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B112-20. PubMed ID: 12180278
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatitis C management: the challenge of dropout associated with male sex and injection drug use.
    Lowry DJ; Ryan JD; Ullah N; Kelleher TB; Crowe J
    Eur J Gastroenterol Hepatol; 2011 Jan; 23(1):32-40. PubMed ID: 21048503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C, interferon alpha and psychiatric co-morbidity in intravenous drug users (IVDU) : guidelines for clinical practice.
    De Bie J; Robaeys G; Buntinx F
    Acta Gastroenterol Belg; 2005; 68(1):68-80. PubMed ID: 15832590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic hepatitis C and individuals with a history of injecting drugs in Spain: population assessment, challenges for successful treatment.
    Roncero C; Littlewood R; Vega P; Martinez-Raga J; Torrens M
    Eur J Gastroenterol Hepatol; 2017 Jun; 29(6):629-633. PubMed ID: 28230562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of hepatitis C virus infection in Australia.
    Dore GJ; MacDonald M; Law MG; Kaldor JM
    Aust Fam Physician; 2003 Oct; 32(10):796-8. PubMed ID: 14596073
    [No Abstract]   [Full Text] [Related]  

  • 9. The burden and recent epidemiological changes of the main chronic liver diseases in a Greek referral tertiary centre.
    Giannousis IP; Papatheodoridis GV; Deutsch MJ; Manolakopoulos SG; Manesis EK; Koskinas JS; Archimandritis AJ
    Eur J Gastroenterol Hepatol; 2010 Feb; 22(2):172-9. PubMed ID: 19738477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment for chronic hepatitis C in a cohort of opiate substitution therapy recipients in three Swedish cities - completion rates and efficacy.
    Jerkeman A; Norkrans G; Lidman C; Westin J; Lagging M; Frimand J; Simonsberg C; Kakko J; Widell A; Björkman P
    Eur J Gastroenterol Hepatol; 2014 May; 26(5):523-31. PubMed ID: 24637496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiological survey of hepatitis C virus infection in a cohort of patients from a ser.T in naples, Italy.
    Curcio F; Villano G; Masucci S; Plenzik M; Veneruso C; De Rosa G
    J Addict Med; 2011 Mar; 5(1):43-9. PubMed ID: 21769046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of Hepatitis C virus re-infection following spontaneous viral clearance in injecting drug users: a systematic review.
    Corson S; Greenhalgh D; Palmateer N; Weir A; Hutchinson S
    Int J Drug Policy; 2011 Mar; 22(2):102-8. PubMed ID: 21112759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chronic hepatitis C?].
    Krook AL
    Tidsskr Nor Laegeforen; 2004 Nov; 124(21):2801-2. PubMed ID: 15534686
    [No Abstract]   [Full Text] [Related]  

  • 14. Methadone and buprenorphine maintenance therapies for patients with hepatitis C virus infected after intravenous drug use.
    Verrando R; Robaeys G; Matheï C; Buntinx F
    Acta Gastroenterol Belg; 2005; 68(1):81-5. PubMed ID: 15832591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of hepatitis C virus core antigenemia in Saudi drug users.
    Alzahrani AJ
    Saudi Med J; 2005 Oct; 26(10):1645-6. PubMed ID: 16228075
    [No Abstract]   [Full Text] [Related]  

  • 16. Incidence of hepatitis C virus and HIV among new injecting drug users in London: prospective cohort study.
    Judd A; Hickman M; Jones S; McDonald T; Parry JV; Stimson GV; Hall AJ
    BMJ; 2005 Jan; 330(7481):24-5. PubMed ID: 15533854
    [No Abstract]   [Full Text] [Related]  

  • 17. The epidemiology of chronic hepatitis C and one-time hepatitis C virus testing of persons born during 1945 to 1965 in the United States.
    Ward JW
    Clin Liver Dis; 2013 Feb; 17(1):1-11. PubMed ID: 23177279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global drug policy fuels hepatitis C epidemic, report warns.
    Clark F
    Lancet; 2013 Jun; 381(9881):1891. PubMed ID: 23734391
    [No Abstract]   [Full Text] [Related]  

  • 19. Hepatitis C virus dynamics among intravenous drug users suggest that an annual treatment uptake above 10% would eliminate the disease by 2030.
    Bruggmann P; Blach S; Deltenre P; Fehr J; Kouyos R; Lavanchy D; Müllhaupt B; Rauch A; Razavi H; Schmid P; Semela D; Stoeckle M; Negro F
    Swiss Med Wkly; 2017; 147():w14543. PubMed ID: 29120012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying former injecting drug users infected with hepatitis C: an evaluation of a general practice-based case-finding intervention.
    Cullen BL; Hutchinson SJ; Cameron SO; Anderson E; Ahmed S; Spence E; Mills PR; Mandeville R; Forrest E; Washington M; Wong R; Fox R; Goldberg DJ
    J Public Health (Oxf); 2012 Mar; 34(1):14-23. PubMed ID: 22138489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.